--- title: "Zeo ScientifiX (ZEOX) stock: news and investor profile" url: "https://aibio.space/companies/zeo-scientifix/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Zeo ScientifiX Inc. (OTC: ZEOX), United States. The directory classifies it as Pharmaceuticals: Major." --- ZEOX Zeo ScientifiX Inc. OTC · United States # Zeo ScientifiX (ZEOX) news Distress · 2026-09-28 ## [Zeo ScientifiX says it cannot file its eight-month transition report on time](https://aibio.space/news/zeo-scientifix-says-cannot-file-eight-month-transition-report-time/) The Form 10-KT covers the eight months ended June 30, 2026. The company expects to file within the 15-day grace period. ## Latest Zeo ScientifiX news 1. 2025-05-12 Financings [Zeo ScientifiX issues 100,000 shares and warrants for 500,000 shares to a consultant](https://aibio.space/news/zeo-scientifix-issues-100-000-shares-warrants-500-000-shares/) The company also granted fully vested options at $2.86 per share to its interim chief executive and directors. ## Zeo ScientifiX at a glance - **Ticker**: ZEOX - **Listing**: OTC - **Country**: United States - **Cash, Apr 30, 2026**: $1.8 million ### Related companies - [TETRALOGIC PHARMACEUTICALS CORP](https://aibio.space/companies/tetralogic-pharmaceuticals/) OTC: TLOG - [SIGA Technologies](https://aibio.space/companies/siga-technologies/) NASDAQ: SIGA - [NOVACCESS GLOBAL INC.](https://aibio.space/companies/novaccess-global/) OTC: XSNX - [Aprea Therapeutics](https://aibio.space/companies/aprea-therapeutics/) NASDAQ: APRE - [Dare Bioscience](https://aibio.space/companies/dare-bioscience/) NASDAQ: DARE - [Acurx Pharmaceuticals](https://aibio.space/companies/acurx-pharmaceuticals/) NASDAQ: ACXP - [Lipella Pharmaceuticals](https://aibio.space/companies/lipella-pharmaceuticals/) OTC: LIPO - [Werewolf Therapeutics](https://aibio.space/companies/werewolf-therapeutics/) NASDAQ: HOWL ### Also on OTC - [Vicapsys Life Sciences](https://aibio.space/companies/vicapsys-life-sciences/) VICP - [Hongchang International Co.](https://aibio.space/companies/hongchang-international/) HCIL - [Rafarma Pharmaceuticals, Inc. (WY)](https://aibio.space/companies/rafarma-pharmaceuticals-wy/) RAFA - [VASO](https://aibio.space/companies/vaso/) VASO - [REBUS HLDGS INC.](https://aibio.space/companies/rebus-hldgs/) RBSH - [Medinotec](https://aibio.space/companies/medinotec/) MDNC ## What Zeo ScientifiX does Zeo ScientifiX Inc. is a clinical-stage biopharmaceutical company focused on biological therapeutics for degenerative diseases and regenerative medicine. Its products are derived from birth tissue, including mesenchymal stem cells, stem cell and amniotic fluid derived exosomes and Whartons Jelly matrix. Its principal product, Zofin, is derived from amniotic fluid and manufactured to retain naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles. The company also makes Patient Pure X (PPX), an autologous biologic containing a nanoparticle fraction precipitated from a patient's own peripheral blood. It sells its products through doctors and clinics and is positioning itself around Florida's stem cell therapy law, SB 1768, effective July 1, 2025. The company has obtained IND and emergency IND approvals from the FDA for clinical use of Zofin, and it has launched an IRB-approved study of PPX in patients with musculoskeletal joint pathologies. In June 2025 it acquired BioLumina, LLC, a seller of topical aesthetic products. It has also sued BioXtek, LLC in Broward County Circuit Court after BioXtek sought to terminate a joint venture. | Product or program | What it is | Stage | |---|---|---| | Zofin | Amniotic fluid derived product retaining extracellular vesicles, proteins and nanoparticles | IND and emergency IND approvals obtained | | Patient Pure X (PPX) | Autologous biologic with a nanoparticle fraction from the patient's own blood | IRB-approved clinical study launched | | Topical aesthetic products | Topical aesthetic products using proprietary ingredients | begun to distribute | Summarised from the company's [10-K filed Jan 29, 2026](https://www.sec.gov/Archives/edgar/data/1557376/000182912626000763/zeoscientifix_10k.htm). ## Zeo ScientifiX annual financials | Line | FY ended Oct 31, 2025 | FY ended Oct 31, 2024 | |---|---|---| | Revenue | [$5.2 million](https://www.sec.gov/Archives/edgar/data/1557376/000182912626000763/) | [$4.6 million](https://www.sec.gov/Archives/edgar/data/1557376/000182912626000763/) | | Research and development | [$100,000](https://www.sec.gov/Archives/edgar/data/1557376/000182912626000763/) | [$164,000](https://www.sec.gov/Archives/edgar/data/1557376/000182912626000763/) | | Net income (loss) | [-$5.5 million](https://www.sec.gov/Archives/edgar/data/1557376/000182912626000763/) | [-$4.7 million](https://www.sec.gov/Archives/edgar/data/1557376/000182912626000763/) | | Cash from operations | [-$718,000](https://www.sec.gov/Archives/edgar/data/1557376/000182912626000763/) | [-$1.4 million](https://www.sec.gov/Archives/edgar/data/1557376/000182912626000763/) | | Cash and equivalents | [$221,000](https://www.sec.gov/Archives/edgar/data/1557376/000182912626006486/) | [$657,000](https://www.sec.gov/Archives/edgar/data/1557376/000182912626006486/) | Latest balance sheet, Apr 30, 2026 (10-Q): cash and equivalents $1.8 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Zeo ScientifiX What is the ticker symbol of Zeo ScientifiX? Zeo ScientifiX Inc. trades under the ticker ZEOX on OTC. Where is Zeo ScientifiX listed? Zeo ScientifiX Inc. is listed on OTC. What is the SEC CIK of Zeo ScientifiX? The SEC Central Index Key (CIK) for Zeo ScientifiX Inc. is 1557376. Its filings are on SEC EDGAR. How many shares does Zeo ScientifiX have outstanding? 7,837,441 shares as of 2026-06-12, per the cover page of its 10-Q filed 2026-06-15. Which country or territory is Zeo ScientifiX listed under? Our directory records Zeo ScientifiX Inc. under United States. What does Zeo ScientifiX do? Our directory classifies Zeo ScientifiX Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Zeo ScientifiX? The ISIN recorded for Zeo ScientifiX Inc. is US68621D2062. Does aibio.space cover Zeo ScientifiX? aibio.space lists Zeo ScientifiX Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Zeo ScientifiX incorporated? SEC records list its state or country of incorporation as NV. What does Zeo ScientifiX develop? Zeo ScientifiX Inc. is a clinical-stage biopharmaceutical company focused on biological therapeutics for degenerative diseases and regenerative medicine. Its products are derived from birth tissue, including mesenchymal stem cells, stem cell and amniotic fluid derived exosomes and Whartons Jelly matrix. What is Zofin from Zeo ScientifiX? Zofin: Amniotic fluid derived product retaining extracellular vesicles, proteins and nanoparticles Stage: IND and emergency IND approvals obtained. What is Patient Pure X (PPX) from Zeo ScientifiX? Patient Pure X (PPX): Autologous biologic with a nanoparticle fraction from the patient's own blood Stage: IRB-approved clinical study launched. What was Zeo ScientifiX's revenue last year? $5.2 million for the fiscal year ended Oct 31, 2025, as reported to the SEC. Is Zeo ScientifiX profitable? Zeo ScientifiX Inc. reported a net loss of $5.5 million for the fiscal year ended Oct 31, 2025, and used $718,000 of cash in operations, per its annual report to the SEC. How much does Zeo ScientifiX spend on research and development? $100,000 in the fiscal year ended Oct 31, 2025, per its annual report. ## Investor discussion: Zeo ScientifiX Members talk about Zeo ScientifiX (ZEOX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Zeo ScientifiX, newest first. Each line links the filing it comes from. 1. 2026-10-30 Financings Reported an unregistered sale of its securities. SEC Form 8-K (Items 1.01,3.02,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1557376/000182912626011800/zeoscientifix_8k.htm) 2. 2026-09-28 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1557376/000182912626010483/zeoscientifix_nt10k.htm) 3. 2026-09-14 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1557376/000182912626010084/zeoscientifix_nt10q.htm) 4. 2026-01-29 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1557376/000182912626000763/zeoscientifix_10k.htm) 5. 2025-05-12 Financings Reported an unregistered sale of its securities. SEC Form 8-K (Items 3.02,5.02). [Source](https://www.sec.gov/Archives/edgar/data/1557376/000182912625003570/zeoscientifix_8k.htm) 6. 2025-01-29 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1557376/000182912625000536/zeoscientifix_10k.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:ZEOX on TradingView](https://www.tradingview.com/symbols/OTC-ZEOX/). ## SEC filings and registration - **SEC name**: Zeo ScientifiX, Inc. - **CIK**: 1557376 - **Industry (SIC)**: Biological Products, (No Diagnostic Substances) (2836) - **US tickers**: ZEOX (OTC) - **State or country of incorporation**: NV - **Fiscal year ends**: June 30 - **Filer category**: Non-accelerated filer
Smaller reporting company - **Business address**: 3321 COLLEGE AVENUE, DAVIE, FL, 33314 - **Phone**: 888-963-7881 - **Shares outstanding**: 7,837,441 as of 2026-06-12 (10-Q filed 2026-06-15) - **Former names**: Organicell Regenerative Medicine, Inc.; Biotech Products Services & Research, Inc.; BESPOKE TRICYCLES INC ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1557376/000182912626010114/zeoscientifix_8k.htm) filed 2026-09-15 - [8-K](https://www.sec.gov/Archives/edgar/data/1557376/000182912626010100/zeoscientifix_8k.htm) filed 2026-09-15 - [8-K](https://www.sec.gov/Archives/edgar/data/1557376/000182912626009583/zeoscientifix_8k.htm) filed 2026-09-01 - [8-K](https://www.sec.gov/Archives/edgar/data/1557376/000182912626008299/zeoscientifix_8k.htm) filed 2026-08-04 - [8-K](https://www.sec.gov/Archives/edgar/data/1557376/000182912626007689/zeoscientifix_8k.htm) filed 2026-07-21 - [8-K](https://www.sec.gov/Archives/edgar/data/1557376/000182912626007394/zeoscientifix_8k.htm) filed 2026-07-08 - [8-K](https://www.sec.gov/Archives/edgar/data/1557376/000182912626007111/zeoscientifix_8k.htm) filed 2026-07-01 - [8-K](https://www.sec.gov/Archives/edgar/data/1557376/000182912626006515/zeoscientifix_8k.htm) filed 2026-06-16 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001557376), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Zeo ScientifiX Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker ZEOX, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Zeo ScientifiX Inc. - **Ticker**: ZEOX - **Listing**: OTC - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US68621D2062 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/OTC-ZEOX/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/zeo-scientifix/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Zeo ScientifiX (ZEOX) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/zeo-scientifix/